RPRD1A and neoplasm: It has been reported that miR-454-3p promotes breast cancer metastasis through targeting nuclear precursor mRNA domain-containing 1A (RPRD1A), a known tumor suppressor, thereby activating Wnt/β-catenin signaling pathway (28).